FT: J&J Looks to Buy Ollin Biosciences for Up to $3.4 Billion
The Financial Times reported that Johnson & Johnson is looking to buy Ollin Biosciences for up to $3.4 billion.
The Financial Times reported that Johnson & Johnson is looking to buy Ollin Biosciences for up to $3.4 billion.